Market Snapshot and Recent Performance
Kingchem Liaoning Life Science Co. Ltd. (ticker 301509.SZ) closed the trading day on Friday, 23 October 2026, without any price change, remaining flat at CNY 25.53. Over the preceding 24 hours, the firm’s shares were traded for a total of CNY 67.3 million, representing a modest volume of 125.3 million outstanding shares. The company’s market capitalization sits at approximately CNY 3.2 billion, with a 200‑day simple moving average of CNY 29.16.
In the last year, the stock has experienced a significant decline, trading down 21.03 % from the month‑end level of the previous period. Nonetheless, the share price has maintained a relatively narrow range, having recorded a 52‑week high of CNY 48.6 on 14 April 2026 and a 52‑week low of CNY 24.96 on 19 October 2026.
Third‑Quarter 2026 Financial Highlights
On 22 October 2026, Kingchem Liaoning Life Science released its third‑quarter earnings report. Revenue grew modestly compared with the prior year, but the company’s net profit attributable to the parent company fell sharply, signalling a pronounced decline in profitability. Earnings per share mirrored this trend, decreasing in line with the bottom line.
Operating cash flow was lower than in the same quarter last year, yet the company reported notable progress in managing its accounts receivable, suggesting a more active cash‑management strategy. Total assets and shareholders’ equity were slightly reduced relative to the previous year, indicating a modest contraction in the company’s balance sheet.
Despite the earnings dip, Kingchem Liaoning Life Science highlighted ongoing expansion of its production capacity, underscored by an increase in construction projects aimed at boosting future output.
Investor Composition
Institutional ownership remains robust, with nine major investors holding approximately 61 % of the shares—a modest rise from the previous quarter. The largest shareholder, Kingchem (China) Holding LLC, continues to retain a substantial stake, providing stability to the ownership structure.
Peer Activity – 24‑Hour Performance
The following table summarises the recent trading activity of related stocks over the past 24 hours:
| Ticker | Current Price | % Change | Market Cap | P/E Ratio |
|---|---|---|---|---|
| 2880.HK (Liaoning Port – H) | HKD 0.66 | –0.75 % | HKD 4.5 bn | 10.31 |
| 000417.SZ (Hefei Department Store) | CNY 5.24 | 0 % | CNY 4.1 bn | 83.28 |
| 600515.SS (Hainan Airport Infrastructure) | CNY 2.62 | 0 % | CNY 4.1 bn | 143.32 |
| 600730.SS (China Hi‑Tech) | CNY 6.50 | 0 % | CNY 4.1 bn | – |
| 300241.SZ (Refond) | CNY 5.39 | 0 % | CNY 3.8 bn | 42.51 |
All peer stocks, aside from Liaoning Port – H, traded flat during the 24‑hour window.
Strategic Outlook
Kingchem Liaoning Life Science’s emphasis on expanding production capacity aligns with its broader growth strategy within the biotechnology sector. While the third‑quarter earnings report revealed challenges in profitability and cash flow, the company’s proactive management of receivables and continued investment in infrastructure signal a commitment to long‑term resilience.
Investors will likely monitor the company’s subsequent quarterly filings for indications of whether the recent revenue uptick translates into sustainable profit improvement, as well as how the new construction projects influence future operating performance.
